Denis S. Korobko
Novosibirsk, NVS, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Long-term safety, tolerability, and efficacy of subcutaneous efgartigimod PH20 in generalized myasthenia gravis: final results from a phase 3 open-label extension study (ADAPT-SC+).
Journal: Frontiers in neurology
Published: May 08, 2026
Epidemiology of multiple sclerosis in the city of Novosibirsk
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: February 11, 2025
Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+).
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: November 14, 2023
POEMS-syndrome
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 10, 2023
Corrigendum to "CLIPPERS: Multiparametric and quantitative MRI features" [Radiology Case Reports 18 (2023) 368-376].
Journal: Radiology case reports
Published: February 23, 2023
Approaches to vaccine prevention in multiple sclerosis
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: September 28, 2022
CLIPPERS: Multiparametric and quantitative MRI features.
Journal: Radiology case reports
Published: August 15, 2022
Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 01, 2022
Local experience of IL-6 pathway inhibition with satralizumab for patients with neuromyelitis optica spectrum disorder
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 01, 2022
Clinical and epidemiological aspects of neuromyelitis optic spectrum diseases in the russian population
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 30, 2021
Susac syndrome, review and clinical case
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: June 04, 2019
Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia.
Journal: PloS one
Published: December 03, 2018
Last Updated: 09/26/2026